Jane Street Group, LLC Graybug Vision, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.93 - $1.18 $10,653 - $13,516	11,455 New	11,455 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.93 - $1.18 $10,653 - $13,516	11,455 New	11,455 $11,000
Q3 2021 Nov 16, 2021	SELL	$3.18 - $5.17 $55,599 - $90,392	-17,484 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.53 - $6.1 $11,617 - $20,075	-3,291 Reduced 15.84%	17,484 $95,000
Q1 2021 May 18, 2021	BUY	$5.55 - $35.0 $115,301 - $727,125	20,775 New	20,775 $115,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.